The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes [Current Research in Toxicology, June 2020]

Profiling the ToxCast library with a pluripotent human (H9) stem cell line-based biomarker assay for developmental toxicity [Toxicological Sciences, February 2020]

A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential [Toxicological Sciences, February 2020]

A Human Induced Pluripotent Stem Cell-Based In Vitro Assay Predicts Developmental Toxicity Through a Retinoic Acid Receptor-Mediated Pathway for a Series of Related Retinoid Analogues [Reproductive Toxicology, 2017]

Stem Cell-Based Methods for Identifying Developmental Toxicity Potential [Predictive Toxicology, 2015]

Establishment and Assessment of a New Human Embryonic Stem Cell-Based Biomarker Assay for Developmental Toxicity Screening [Birth Defects Research, 2013]

Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics

Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics